HorStem is the world's first medicine based on equine umbilical cord mesenchymal stem cells authorized by centralized registration by the European Medicines Agency.
HorStem is an injectable suspension indicated for the reduction of lameness associated with mild to moderate degenerative joint disease in horses.
HorStem contains 15 million Equine Umbilical Cord Stem Cells as its active ingredient.
It is a veterinary prescription drug. It has been specially designed in a "ready-to-use" format that allows for easy and safe injection under field conditions without the need for handling and/or thawing by the veterinarian.
*High-strength, puncture-resistant vial that ensures the sterility, viability, and quality of the product at all times.
Pluripotent Mesenchymal Cells
Regenerative medicine without systemic adverse effects